02112 恩典生命科技
按盘价 
0.124 -0.003 (-2.362%) 盈利能力分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 资产回报率 (%) | -32.631% | -36.349% | -27.936% | -11.578% | -19.728% |
| 股东资金回报率 (%) | N/A | N/A | -1170.675% | -48.225% | -47.622% |
| 资本运用回报率 (%) | N/A | N/A | N/A | -78.980% | -60.696% |
边际利润分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 毛利率 (%) | 10.453% | 7.849% | 0.684% | -2.050% | 1.097% |
| 未计利息、税项、折旧及摊销前利润率 (%) | -87.103% | -131.552% | -189.695% | -47.851% | -3.703% |
| 税前边际利润率 (%) | -142.928% | -173.011% | -237.743% | -107.173% | -5.391% |
| 纯利率 (%) | -145.170% | -172.319% | -237.743% | -106.268% | -5.412% |
变现能力分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 流动比率 (X) | 0.404 X | 0.545 X | 0.791 X | 1.076 X | 1.339 X |
| 速动比率 (X) | 0.399 X | 0.543 X | 0.791 X | 1.076 X | 1.339 X |
财务杠杆分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 总负债 / 总资产比率 (%) | 210.051% | 160.139% | 114.021% | 85.526% | 67.258% |
| 总债项 / 总资产比率 (%) | 111.098% | 83.535% | 61.515% | 42.769% | 34.668% |
| 净债项 / 总资产比率 (%) | 110.978% | 83.398% | 60.827% | 42.725% | 34.631% |
| 总债项 / 股东资金比率 (%) | N/A | N/A | N/A | 295.478% | 107.956% |
| 长期债项 / 股东资金比率 (%) | N/A | N/A | N/A | 0.032% | 0.188% |
| 净债项 / 股东资金比率 (%) | N/A | N/A | N/A | 295.178% | 107.841% |
| 净现金 / (债项) ($) | (1.21亿) | (1.11亿) | (1.05亿) | (1.00亿) | (9.57千万) |
| 每股净现金 / (债项) ($) | (0.081) | (0.074) | (0.070) | (0.067) | (0.064) |
| 总债项 / 资本运用比率 (%) | N/A | N/A | N/A | 268.153% | 101.825% |
| 利息盈利率 (X) | N/A | N/A | N/A | N/A | N/A |
营运效率分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 存货周转率日数 (日) | 11.321日 | 5.755日 | N/A | N/A | N/A |
| 应收贸易帐周转率日数 (日) | 1361.816日 | 1479.075日 | 2682.342日 | 2765.371日 | 73.168日 |
| 应付贸易帐周转率日数 (日) | 95.171日 | 52.453日 | 70.784日 | 122.053日 | 2.118日 |
| 备注： | 实时报价更新时间为29/11/2024 14:53 |
| 港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |
| 股东应占溢利/(亏损) () | USD -8,966,000 |
| 增长率 | -14.291% |
| 每股盈利/(亏损) | USD -0.006 |
| 每股账面资产净值 ($) | USD -0.086 |